Free Trial
ASX:CYC

Cyclopharm (CYC) Stock Price, News & Analysis

About Cyclopharm Stock (ASX:CYC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
10,000 shs
Average Volume
N/A
Market Capitalization
A$219.50 million
P/E Ratio
N/A
Dividend Yield
0.74%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyclopharm and its competitors with MarketBeat's FREE daily newsletter.

CYC Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:CYC
CIK
N/A
Fax
N/A
Employees
87
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$9.32 million
Net Margins
-40.69%
Pretax Margin
N/A
Return on Equity
-23.34%
Return on Assets
-15.37%

Debt

Debt-to-Equity Ratio
11.72
Current Ratio
4.38
Quick Ratio
4.68

Sales & Book Value

Annual Sales
A$24.06 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
8.40
Book Value
A$0.50 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
111,140,000
Free Float
N/A
Market Cap
A$219.50 million
Optionable
Not Optionable
Beta
0.70
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (ASX:CYC) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners